Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: Psychosocial outcomes

American Journal of Psychiatry

Volumn 154, Issue 3, 1997, Pages 390-395

  Kocsis, James H ^h   Zisook, Sidney ^a   Davidson, Jonathan ^b   Shelton, Richard ^c   Yonkers, Kimberly ^d   Hellerstein, David J ^e   Rosenbaum, Jerrold ^f   Halbreich, Uriel ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY AT BUFFALO   (United States)

^h WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; SERTRALINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEPRESSION; DOUBLE BLIND PROCEDURE; DYSTHYMIA; FEMALE; HUMAN; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; MOOD; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUALITY;

EID: 0031018776     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.3.390     Document Type: Article

References (36)

1. Keller MB: Current concepts of affective disorders. J Clin Psychiatry 1989; 50:157-162
2. Bakish D, LaPierre YD, Weinstein R, Klein J, Wiens A, Jones B, Horn E, Browne M, Bourget O, Blanchard A: Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder. J Clin Psychopharmacol 1993; 13:409-414
3. Regier DA, Boyd JH, Burke JD Jr, Rae DS, Myers JK, Kramer M, Robins LN, George LK, Karno M, Locke BZ: One-month prevalence of mental disorders in the United States: based on five Epidemiologic Catchment Area sites. Arch Gen Psychiatry 1988; 45:977-986
4. Keller MB: Dysthymia in clinical practice: course outcome and impact on the community. Acta Psychiatr Scand Suppl 1994; 383:24-34
5. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51:8-19
6. Spitzer RL, Williams JBW, Kroenke K, Linzer M, deGruy FV, Hahn SR, Brody D, Johnson JG: Utility of a new procedure for diagnosing mental disorders in primary care; the PRIME-MD 1000 Study. JAMA 1994; 272:1749-1756
7. Johnson J, Weissman MM, Kerman GL: Service utilization and social morbidity associated with depressive symptoms in the community. JAMA 1992; 267:1478-1483
8. Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, Berry S, Greenfield S, Ware J: The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989; 262:914-919
9. Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JBW, deGruy FV, Brody D, Davies M: Health-related quality of life in primary care patients with mental 'disorders: results from the PRIME-MD 1000 Study. JAMA 1995; 274:1511-1517
10. Cassano GB, Perugi G, Musetti L, Akiskal HS: The nature of depression presenting concomitantly with panic disorder. Compr Psychiatry 1989; 30:473-482
11. Lonnqvist J, Sintonen H, Syvalahti E, Appelberg B, Koskinen T, Mannikko T, Mehtonen O-P, Naaraku M, Sihvo S, Auvinen J, Pitkanen H: Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine. Acta Psychiatr Scand 1994; 89:363-369
12. Turner R: Quality of life: experience with sertraline. Int Clin Psychopharmacol 1994; 9(suppl 3):27-31
13. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry I960; 23:56-62
14. Shapiro R, Keller M: Longitudinal Interval Follow-up Evaluation (LIFE). Boston, Lindemann Mental Health Center, 1979
15. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389
16. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L: The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 1974; 19:1-15
17. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C: The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1986; 18:65-87
18. Rush AJ, Hiser W, Giles DE: A comparison of self-reported versus clinician-rated symptoms in depression. J Clin Psychiatry 1987; 48:246-248
19. Weissman MM, Bothwell S: Assessment of social adjustment by patient self-report. Arch Gen Psychiatry 1976; 33:1111-1115
20. Endicott J, Nee J, Harrison W, Blumenthal R: Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993; 29:321-326
21. Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W: A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 1996; 53:777-784
22. SAS User's Guide, Statistics, version 6. Gary, NC, SAS Institute, 1989
23. Weissman MM, Prusoff BA, Thompson WD, Harding PS, Myers JK: Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis 1978; 166:317-326
24. Weissman MM, Klerman GL, Paykel ES: Treatment effects on the social adjustment of depressed patients. Arch Gen Psychiatry 1981; 38:51-55
25. Weissman MM, Klerman GL, Prusoff BA, Sholomskas D, Padian N: Depressed outpatients: results one year after treatment with drugs and/or interpersonal therapy. Arch Gen Psychiatry 1981; 38:51-55
26. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP, Fiester SJ, Parloff MB: National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry 1989; 46:971-982
27. Agosti V, Stewart JW, Quitkin FM: Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants. J Affect Disord 1991; 23:35-41
28. Perugi G, Maremmani I, McNair DM, Cassano GB, Akiskal HS: Differential changes in areas of social adjustment from depressive episodes through recovery. J Affect Disord 1988; 15:39-43
29. De Lisio G, Maremmani I, Perugi G, Cassano GB, Deltito J, Akiskal HS: Impairment of work and leisure in depressed outpatients: a preliminary communication. J Affect Disord 1986; 10:79-84
30. Kocsis JH, Sutton BM, Frances AJ: Long-term follow-up of chronic depression treated with imipramine. J Clin Psychiatry 1991; 52:56-59
31. Kocsis JH, Frances AJ, Voss C, Mason BJ, Mann JJ, Sweeney J: Imipramine and social-vocational adjustment in chronic depression. Am J Psychiatry 1988; 145:997-999
32. Stewart JW, Quitkin FM, McGrath PJ, Rabkin JB, Markowitz JC, Tricarno E, Klein DF: Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment. Psychiatry Res 1988; 25:213-222
33. Kocsis JH, Frances AJ, Voss C, Mann JJ, Mason BJ, Sweeney J: Imipramine treatment for chronic depression. Arch Gen Psychiatry 1988; 45:253-257
34. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER: The economic burden of depression in 1990. J Clin Psychiatry 1993; 54:405-418
35. Tollefson GD, Souetre E, Thomander L, Potvin JH: Comorbid anxious signs and symptoms in major depression: impact on functional work capacity and comparative treatment outcomes. Int Clin Psychopharmacol 1993; 8:281-293
36. Mintz J, Mintz LI, Arruda MJ: Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992; 49:761-768